Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning versus evening hydroxyzine dosing and cognition in healthy adults
NL-OMON33183Phase 4Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydroxyzine, sponsored by Maastricht University. Primary endpoint: Mean Absolute Tracking Error in the Divided Attention Task. Started Sep 2009; status: active, not recruiting.
02
Drugs
hydroxyzine
Beyond the preview
Go deeper on NL-OMON33183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33183.